In light of the above mentioned evidence supporting the role of ARS-induced NF-κB-CX3CL1 signaling upregulation in the CeA, we next examined the mechanisms potentially responsible for initiating this process in ARS. The gene discussed is CX3CL1; the disease is Axenfeld-Rieger syndrome.